UNIVERSITY OF NEW MEXICO
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1889-01-01
- Employees
- 6.7K
- Market Cap
- -
- Website
- https://www.unm.edu/
Lung Cancer Case Registry and Tissue Resource
Terminated
- Conditions
- Lung Cancer
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 750
- Registration Number
- NCT00250848
- Locations
- ๐บ๐ธ
New Mexico Veterans Administration Health Care System, Albuquerque, New Mexico, United States
๐บ๐ธUniversity of New Mexico Cancer Center, Albuquerque, New Mexico, United States
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
Completed
- Conditions
- Uterine NeoplasmsEndometrial Neoplasms
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 26
- Registration Number
- NCT00250783
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
Withdrawn
- Conditions
- Endometrial NeoplasmsUterine Neoplasms
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- University of New Mexico
- Registration Number
- NCT00250770
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Pharmacology Study of Aerosolized Liposomal
Phase 2
Withdrawn
- Conditions
- CancerLung Diseases
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- University of New Mexico
- Registration Number
- NCT00250120
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Phase 2
Completed
- Conditions
- Lung DiseasesCancer
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2010-05-19
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 8
- Registration Number
- NCT00250068
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Phase 2
Completed
- Conditions
- Corpus UteriEndometrial Cancer
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 39
- Registration Number
- NCT00249990
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
Phase 1
Completed
- Conditions
- Solid TumorsCancer
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 21
- Registration Number
- NCT00249977
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
Not Applicable
Terminated
- Conditions
- CervixCancer
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 100
- Registration Number
- NCT00250055
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
Withdrawn
- Conditions
- Corpus UteriEndometrial Cancer
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- University of New Mexico
- Registration Number
- NCT00250016
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Immune Dysfunction in Allergic Asthma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2019-09-27
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 18
- Registration Number
- NCT00189228
- Locations
- ๐บ๐ธ
UNM HSC, Albuquerque, New Mexico, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath